Diabetes as a cause of death across different COVID-19 epidemic waves. (August 2022)

• Record Type: Journal Article
• Authors: Fedeli, Ugo; Casotto, Veronica; Schievano, Elena; Bonora, Enzo; Zoppini, Giacomo
• Is Part Of: Diabetes research and clinical practice. Volume 190(2022)
• Publication Date: 2022-08
• Subjects: Diabetes -- Mortality -- Time series -- Covid-19, seasonality, trends; Diabetes -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462
• DOI: 10.1016/j.diabres.2022.109984
• Languages: English
• ISSNs: 0168-8227

Abstract

Abstract: Aims: The aim of this study is to assess the role of diabetes as a cause of death through different epidemic waves of COVID-19. Methods: The annual percentage change in age-standardized rates (APC) was estimated for diabetes as the underlying (UCOD) and as multiple causes of death (MCOD) in 2008–2019. Diabetes-related deaths in 2020 were compared to the 2018–2019 average. SARIMA models were applied to monthly excess in mortality considering seasonality and long-term trends. Results: 2018–2019-Age-standardized mortality rates decreased, especially among females (MCOD: APC −2.49, 95%CI −3.01/-1.97%). In 2020, deaths increased by 19% (95%CI 13–25%) for UCOD, and by 27% (95%CI 24–30%) for MCOD. Diabetes and COVID-19 accounted for 74% of such excess. During the first epidemic wave, the increase in observed rates vs predicted by the model was larger in males (March +39%, April +46%) than in females (+30% and +32%). In the second wave, a huge excess of similar magnitude was observed in the two sexes; rates in December exceeded those predicted by more than 100%. Conclusions: The COVID-19 pandemic abruptly interrupted a long-term declining trend in mortality associated to diabetes. MCOD analyses are warranted to fully estimate the impact of epidemic waves on diabetes-related mortality.